Gut Microbes
Volume 11, 2020 - Issue 5
Open access
4,698
Views
38
CrossRef citations to date
0
Altmetric
Research paper/report
The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin
Tsutomu Yoshiharaa Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Japan
https://orcid.org/0000-0001-5150-7942View further author information
Yosuke Oikawab R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, JapanView further author information
, Takayuki Katoc Department of Gastroenterology, International University of Health and Welfare Atami Hospital, Atami, Japan
https://orcid.org/0000-0001-8839-9594View further author information
Takaomi Kessokua Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, JapanView further author information
, Takashi Kobayashia Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, JapanView further author information
, Shingo Katoa Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, JapanView further author information
, Noboru Misawaa Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, JapanView further author information
, Keiichi Ashikaria Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Japan
https://orcid.org/0000-0001-8379-4704View further author information
Akiko Fuyukia Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, JapanView further author information
, Hidenori Ohkuboa Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, JapanView further author information
, Takuma Higurashia Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, JapanView further author information
, Yoko Tateishid Department of Pathology, Yokohama City University Hospital, Yokohama, JapanView further author information
, Yoshiki Tanakab R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, JapanView further author information
, Shunji Nakajimab R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, JapanView further author information
, Hiroshi Ohnob R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, JapanView further author information
, Koichiro Wadae Department of Pharmacology, Faculty of Medicine, Shimane University, Izumo, Japan
https://orcid.org/0000-0001-9231-0556View further author information
Atsushi Nakajimaa Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, JapanCorrespondence[email protected]
View further author information
show allView further author information
Pages 1385-1404
|
Received 14 Aug 2019, Accepted 03 Apr 2020, Published online: 09 Jun 2020
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.